COA in PROgress
The use of COA in patient-centered drug development: part 2
Apr 10, 2024
Health technology assessment expert Paul Miller and patient-reported outcomes specialist Olivier Wong delve into the integration of patient perspectives in decision-making processes, the significance of high-quality patient experience data, the challenges of aligning methodologies for joint clinical assessments, and the evolution of patient-reported outcomes in health technology assessment.
36:12
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Scientific rigor in capturing patient experience data is crucial in incorporating PROs effectively into the HTA process.
- Harmonization across different health systems is a challenge for standardized incorporation of PROs in decision-making processes.
Deep dives
Usage of Patient Reported Outcomes (PROs) in Health Technology Agencies (HTAs)
Patient Reported Outcomes (PROs) have gained importance in health technology agency decision-making processes. Documentation, like the Nice Health Technology Evaluations Manual, includes guidelines for capturing patient and caregiver experiences. However, while there is recognition of the importance of patient experiences, challenges remain in scientific methodologies for incorporating PRO data effectively into the HTA process. There is a push towards increasing scientific rigor in capturing patient experience data and addressing the methodological considerations.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
